KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBITDA: 2011-2024

Historic EBITDA for Precigen (PGEN) over the last 14 years, with Dec 2024 value amounting to -$135.0 million.

  • Precigen's EBITDA fell 62.17% to -$34.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.4 million, marking a year-over-year increase of 16.61%. This contributed to the annual value of -$135.0 million for FY2024, which is 35.36% down from last year.
  • Precigen's EBITDA amounted to -$135.0 million in FY2024, which was down 35.36% from -$99.8 million recorded in FY2023.
  • In the past 5 years, Precigen's EBITDA registered a high of -$75.7 million during FY2022, and its lowest value of -$135.0 million during FY2024.
  • In the last 3 years, Precigen's EBITDA had a median value of -$99.8 million in 2023 and averaged -$103.5 million.
  • In the last 5 years, Precigen's EBITDA soared by 50.26% in 2020 and then tumbled by 35.36% in 2024.
  • Yearly analysis of 5 years shows Precigen's EBITDA stood at -$78.9 million in 2020, then declined by 8.72% to -$85.7 million in 2021, then increased by 11.69% to -$75.7 million in 2022, then tumbled by 31.74% to -$99.8 million in 2023, then crashed by 35.36% to -$135.0 million in 2024.